Exogenous IL-13 showed a strong supporting role, since the addition of exogenous IL-13 produced an MDSC subset that was more effective in preventing GVHD and demonstrated increased ARG1 activity [27]. The gene discussed is ARG1; the disease is graft versus host disease.